Skip to main content

Table 2 Patient demographics and infection characteristics at ED presentation

From: Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department

Demographic/Characteristic Number (%), unless otherwise specified
(n = 94)
Age, years, mean ± SD 52.8 ± 15.0
Male Gender 50 (53.2)
Total Body Weight, kilograms, mean ± SD 97.6 ± 37.2
Race
 White 76 (80.9)
 Black/African American 17 (18.1)
 Unknown 1 (1.1)
Co-morbidities
 Diabetes (Type 1 or 2) 30 (31.9)
 Peripheral Vascular Disease 8 (8.5)
 Chronic Kidney Disease 13 (13.8)
 Congestive Heart Failure 14 (14.9)
 Coronary Artery Disease 17 (18.1)
 COPD, Asthma, or Emphysema 14 (14.9)
 Acute or Chronic Liver Disease 5 (5.3)
 Active Malignancy 7 (7.4)
 HIV/AIDS 2 (2.1)
 Other Immunosuppressive disease 7 (7.4)
Charlson Comorbidity Index, median (25th, 75th percentile) 2 (0, 4)
Education, 4 year college degree or greater 12 (12.8)
Employment, working full or part-time 40 (43)
Skin Infection Characteristics
 Cellulitis/erysipelas only 50 (53.2)
 Cutaneous abscess only 1 (1.1)
 Wound infection only 10 (10.6)
 Cellulitis + abscess 17 (18.1)
 Cellulitis + wound infection 13 (13.8)
 Abscess + wound infection 1 (1.1)
 Cellulitis + abscess + wound infection 2 (2.1)
Lesion Size, cm2, Mean ± SD 522.01 ± 806.5
 Met ABSSSI definition (≥ 75 cm2) 78 (83)
Fever on ED Presentation 9 (9.6)
Leukocytosis on ED Presentation (Normal range: 4–12 cells/mm3) 24 (25.5)
History of Previous ABSSSI 60 (63.8)
 Relapse/failure/readmission for an ongoing ABSSSI episode (n = 60) 29 (48.3)
 Previously received IV antibiotics for an ABSSSI episode (n = 60) 38 (63.3)
Microbiology
 Patients with Culture Collected 32 (34.0)
  Patients with Bacteria Isolated 31 (96.8)
   Patients with Gram-positive 28 (87.5)
   Patients with Gram-negative 9 (28.1)
   Patients with anaerobe 3 (9.4)
   Patients with multiple bacteria on culture 14 (43.8)
   Number of Organisms Isolated 60
    Gram-positives 43 (71.7)
     Staphylococcus aureus 23 (38.3)
      MRSA rate 7 (30.4)
     β-hemolytic streptococci 12 (20)
     Other 8 (13.2)
    Gram-negatives (all Enterobacteriaceae) 11 (18.3)
  1. COPD Chronic Obstructive Pulmonary Disorder, HIV/AIDS, Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, MRSA Methicillin-resistant Staphylococcus aureus